LogicBio Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
62
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$72M
- Investors
-
2
LogicBio Therapeutics General Information
Description
LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.
Contact Information
Website
www.logicbio.comCorporate Office
- 65 Hayden Avenue
- Lexington, MA 02421
- United States
Corporate Office
- 65 Hayden Avenue
- Lexington, MA 02421
- United States
LogicBio Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 16-Nov-2022 | $72M | Completed | Generating Revenue | ||
| 3. IPO | 19-Oct-2018 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series B) | 27-Jun-2017 | $44.9M | $49.9M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC (Series A) | 20-Jan-2016 | $5M | $5M | Completed | Pre-Clinical Trials |
LogicBio Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
LogicBio Therapeutics Comparisons
Industry
Financing
Details
LogicBio Therapeutics Competitors (76)
One of LogicBio Therapeutics’s 76 competitors is Intellia Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Voyager Therapeutics | Corporation | Lexington, MA | ||||
| ProFactor Pharma | Venture Capital-Backed | Roslin, United Kingdom | ||||
| CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland | ||||
| Qrons | Corporation | New York, NY |
LogicBio Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
LogicBio Therapeutics Patents
LogicBio Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023275457-A1 | Gene therapy compositions and methods of use thereof | Pending | 23-May-2022 | ||
| CA-3235208-A1 | Gene therapy for the treatment of ht1 | Pending | 18-Oct-2021 | ||
| CA-3235195-A1 | Gene therapy for the treatment of wilson's disease | Pending | 18-Oct-2021 | ||
| EP-4419659-A2 | Gene therapy for the treatment of ht1 | Pending | 18-Oct-2021 | ||
| EP-4419671-A2 | Gene therapy for the treatment of wilson's disease | Pending | 18-Oct-2021 | A61K48/005 |
LogicBio Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LogicBio Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arix Bioscience | Venture Capital | Minority | ||
| OrbiMed | Growth/Expansion | Minority |
LogicBio Therapeutics ESG
Risk Overview
Risk Rating
Updated July, 22, 2020
42.69 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,042
Rank
Percentile
Pharmaceuticals
Industry
of 947
Rank
Percentile
Pharmaceuticals
Subindustry
of 452
Rank
Percentile
LogicBio Therapeutics FAQs
-
When was LogicBio Therapeutics founded?
LogicBio Therapeutics was founded in 2014.
-
Where is LogicBio Therapeutics headquartered?
LogicBio Therapeutics is headquartered in Lexington, MA.
-
What is the size of LogicBio Therapeutics?
LogicBio Therapeutics has 62 total employees.
-
What industry is LogicBio Therapeutics in?
LogicBio Therapeutics’s primary industry is Biotechnology.
-
Is LogicBio Therapeutics a private or public company?
LogicBio Therapeutics is a Private company.
-
What is the current valuation of LogicBio Therapeutics?
The current valuation of LogicBio Therapeutics is .
-
What is LogicBio Therapeutics’s current revenue?
The current revenue for LogicBio Therapeutics is .
-
How much funding has LogicBio Therapeutics raised over time?
LogicBio Therapeutics has raised $120M.
-
Who are LogicBio Therapeutics’s investors?
Arix Bioscience and OrbiMed have invested in LogicBio Therapeutics.
-
Who are LogicBio Therapeutics’s competitors?
Intellia Therapeutics, Voyager Therapeutics, ProFactor Pharma, CRISPR Therapeutics, and Qrons are some of the 76 competitors of LogicBio Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
